标题
Current therapeutic approaches to diffuse grade II and III gliomas
作者
关键词
-
出版物
Therapeutic Advances in Neurological Disorders
Volume 11, Issue -, Pages 175628561775203
出版商
SAGE Publications
发表日期
2018-01-19
DOI
10.1177/1756285617752039
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Identifying clinical risk in low grade gliomas and appropriate treatment strategies, with special emphasis on the role of surgery
- (2017) Sébastien Boissonneau et al. Expert Review of Anticancer Therapy
- Diffuse Infiltrating Oligodendroglioma and Astrocytoma
- (2017) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study
- (2017) Martin J van den Bent et al. LANCET
- European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
- (2017) Michael Weller et al. LANCET ONCOLOGY
- Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy
- (2017) Tiffany R. Hodges et al. NEURO-ONCOLOGY
- OS10.3 Randomized Phase 3 Study Evaluating the Efficacy and Safety of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: CheckMate 143
- (2017) D. A. Reardon et al. NEURO-ONCOLOGY
- Supratotal resection of diffuse gliomas – an overview of its multifaceted implications
- (2017) Y.N. Yordanova et al. NEUROCHIRURGIE
- 2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity
- (2017) Parker L. Sulkowski et al. Science Translational Medicine
- Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort
- (2016) Emeline Tabouret et al. ACTA NEUROPATHOLOGICA
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Abstract 3101: The mutant IDH1 inhibitor prevents growth of glioblastoma with IDH1 mutation in patient-derived xenograft (PDX) model
- (2016) Yukino Machida et al. CANCER RESEARCH
- Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
- (2016) Eric Bouffet et al. JOURNAL OF CLINICAL ONCOLOGY
- Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
- (2016) Brigitta G Baumert et al. LANCET ONCOLOGY
- Clonal evolution of glioblastoma under therapy
- (2016) Jiguang Wang et al. NATURE GENETICS
- Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
- (2016) Jan C. Buckner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Residual Tumor Volume as Best Outcome Predictor in Low Grade Glioma – A Nine-Years Near-Randomized Survey of Surgery vs. Biopsy
- (2016) Roland Roelz et al. Scientific Reports
- Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment
- (2015) Hinke F. van Thuijl et al. ACTA NEUROPATHOLOGICA
- Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma
- (2015) A. L. Di Stefano et al. CLINICAL CANCER RESEARCH
- Chemotherapy for low-grade glioma
- (2015) Martin J. van den Bent CURRENT OPINION IN NEUROLOGY
- Anaplastic glioma: current treatment and management
- (2015) Emilie Le Rhun et al. Expert Review of Neurotherapeutics
- Mutational landscape and clonal architecture in grade II and III gliomas
- (2015) Hiromichi Suzuki et al. NATURE GENETICS
- ATPS-68COMBINATION OF TOPOISOMERASE II POISON BERUBICIN WITH STAT3 INHIBITOR WP1066BLOCKS POTENTLY TUMOR GROWTH IN GMB MODELS
- (2015) Rafal Zielinski et al. NEURO-ONCOLOGY
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
- (2015) David M. Hyman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- TCF12 is mutated in anaplastic oligodendroglioma
- (2015) Karim Labreche et al. Nature Communications
- Combination genetic signature stratifies lower-grade gliomas better than histological grade
- (2015) Aden Ka-Yin Chan et al. Oncotarget
- Anaplastic glioma: current treatment and management
- (2015) Emilie Le Rhun et al. Expert Review of Neurotherapeutics
- Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma
- (2015) Serena Pellegatta et al. Acta Neuropathologica Communications
- Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma
- (2015) Emily Padfield et al. Frontiers in Oncology
- The genetic landscape of anaplastic astrocytoma
- (2015) Patrick J. Killela et al. Oncotarget
- 5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft
- (2015) Alexandra Borodovsky et al. Oncotarget
- Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT Inhibitor Decitabine.
- (2015) Sevin Turcan et al. Oncotarget
- Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation ofIDH
- (2014) J. Gregory Cairncross et al. JOURNAL OF CLINICAL ONCOLOGY
- A vaccine targeting mutant IDH1 induces antitumour immunity
- (2014) Theresa Schumacher et al. NATURE
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- Reoperation for Recurrent High-Grade Glioma
- (2014) Shawn L. Hervey-Jumper et al. NEUROSURGERY
- Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss
- (2013) Hideyuki Arita et al. ACTA NEUROPATHOLOGICA
- Epileptic seizures in diffuse low-grade gliomas in adults
- (2013) Johan Pallud et al. BRAIN
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Anti-PD-1 Blockade and Stereotactic Radiation Produce Long-Term Survival in Mice With Intracranial Gliomas
- (2013) Jing Zeng et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials
- (2013) T. Gorlia et al. NEURO-ONCOLOGY
- IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection
- (2013) Jason Beiko et al. NEURO-ONCOLOGY
- Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation
- (2013) W. Wick et al. NEUROLOGY
- Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma
- (2013) B. E. Johnson et al. SCIENCE
- An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
- (2013) D. Rohle et al. SCIENCE
- CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas
- (2012) Felix Sahm et al. ACTA NEUROPATHOLOGICA
- Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations
- (2012) Xiao-Yang Liu et al. ACTA NEUROPATHOLOGICA
- Randomized Trial of Radiation Therapy Plus Procarbazine, Lomustine, and Vincristine Chemotherapy for Supratentorial Adult Low-Grade Glioma: Initial Results of RTOG 9802
- (2012) Edward G. Shaw et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
- (2012) Gregory Cairncross et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951
- (2012) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- Sequential Immunotherapy by Vaccination With GM-CSF–expressing Glioma Cells and CTLA-4 Blockade Effectively Treats Established Murine Intracranial Tumors
- (2012) Pankaj Agarwalla et al. JOURNAL OF IMMUNOTHERAPY
- IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
- (2012) Sevin Turcan et al. NATURE
- Initial treatment patterns over time for anaplastic oligodendroglial tumors
- (2012) K. S. Panageas et al. NEURO-ONCOLOGY
- Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma
- (2012) D. Singh et al. SCIENCE
- IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma
- (2011) Qi SongTao et al. CANCER SCIENCE
- Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers
- (2011) Stephen Yip et al. JOURNAL OF PATHOLOGY
- A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma
- (2011) T. N. Kreisl et al. NEURO-ONCOLOGY
- International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors
- (2011) A. B. Lassman et al. NEURO-ONCOLOGY
- Efficacy of Gamma Knife Radiosurgery for Small-Volume Recurrent Malignant Gliomas After Initial Radical Resection
- (2011) Robert E. Elliott et al. World Neurosurgery
- Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis
- (2010) Philippe Metellus et al. ACTA NEUROPATHOLOGICA
- Management of Low-Grade Glioma
- (2010) Nader Pouratian et al. Current Neurology and Neuroscience Reports
- Diagnostic and prognostic value of alpha internexin expression in a series of 409 gliomas
- (2010) François Ducray et al. EUROPEAN JOURNAL OF CANCER
- Hypofractionated Stereotactic Radiation Therapy: An Effective Therapy for Recurrent High-Grade Gliomas
- (2010) Shannon E. Fogh et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study
- (2010) James R. Perry et al. JOURNAL OF CLINICAL ONCOLOGY
- Early or delayed radiosurgery for WHO grade II astrocytomas
- (2010) Kyung-Jae Park et al. JOURNAL OF NEURO-ONCOLOGY
- Prolonged response without prolonged chemotherapy: a lesson from PCV chemotherapy in low-grade gliomas
- (2010) M. Peyre et al. NEURO-ONCOLOGY
- IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
- (2010) C. Houillier et al. NEUROLOGY
- All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2
- (2010) M. Labussiere et al. NEUROLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term outcome and survival of surgically treated supratentorial low-grade glioma in adult patients
- (2009) Rezvan Ahmadi et al. ACTA NEUROCHIRURGICA
- Monoclonal antibody specific for IDH1 R132H mutation
- (2009) David Capper et al. ACTA NEUROPATHOLOGICA
- IDH1 Mutations Are Early Events in the Development of Astrocytomas and Oligodendrogliomas
- (2009) Takuya Watanabe et al. AMERICAN JOURNAL OF PATHOLOGY
- Bevacizumab for recurrent alkylator-refractory anaplastic oligodendroglioma
- (2009) Marc C. Chamberlain et al. CANCER
- Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
- (2009) Marc Sanson et al. JOURNAL OF CLINICAL ONCOLOGY
- NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
- (2009) Wolfgang Wick et al. JOURNAL OF CLINICAL ONCOLOGY
- Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up
- (2009) Linda Douw et al. LANCET NEUROLOGY
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- (2009) Lenny Dang et al. NATURE
- Bevacizumab and irinotecan for recurrent oligodendroglial tumors
- (2009) S. Taillibert et al. NEUROLOGY
- Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant Gliomas
- (2008) A. Desjardins et al. CLINICAL CANCER RESEARCH
- Phase II Study of Protracted Daily Temozolomide for Low-Grade Gliomas in Adults
- (2008) S. Kesari et al. CLINICAL CANCER RESEARCH
- Preoperative prognostic classification system for hemispheric low-grade gliomas in adults
- (2008) Edward F. Chang et al. JOURNAL OF NEUROSURGERY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started